JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Corrigendum to the Outcome of the first Board Meeting held on 21 January 2026
JBCHEPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
JB Chemicals & Pharmaceuticals Limited has filed a corrigendum to the outcome of its first board meeting held on 21 January 2026. A corrigendum is a correction or amendment issued to a previously filed disclosure, suggesting that some details from the original board meeting outcome announcement have been revised or updated. No specific details on what was corrected are available from this filing alone. Investors should refer to the corrigendum document or the original outcome filing for the revised information.
Corrigendums are typically minor corrections and rarely cause material movement in stock price, but investors should review the changes to ensure they have accurate information on any decisions made at the January board meeting, such as financial results, dividends, or other key matters.